Lantheus Holdings Company Profile (NASDAQ:LNTH)

About Lantheus Holdings (NASDAQ:LNTH)

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

Industry, Sector and Symbol:

Sector: Medical
Industry: Diagnostic & Testing Substances
Sub-Industry: N/A
Symbol: NASDAQ:LNTH
CUSIP: N/A
Web: investor.lantheus.com

Capitalization:

Market Cap: $662.98 million
Outstanding Shares: 37,351,000

Average Prices:

50 Day Moving Avg: $17.64
200 Day Moving Avg: $17.64
52 Week Range: $7.65 - $20.45

P/E:

Trailing P/E Ratio: 24.39
Foreward P/E Ratio: 16.08
P/E Growth: 0.69

Sales & Book Value:

Annual Revenue: $317.61 million
Price / Sales: 2.10
Book Value: ($2.33) per share
Price / Book: -7.66

Profitability:

EBITDA: $75.23 million
Net Margins: 8.44%
Return on Equity: -37.47%
Return on Assets: 15.16%

Debt:

Debt-to-Equity Ratio: -3.05%
Current Ratio: 2.92%
Quick Ratio: 2.43%

Misc:

Average Volume: 456,588 shs.
Beta: 0.91
Short Ratio: 3.21

Frequently Asked Questions for Lantheus Holdings (NASDAQ:LNTH)

What is Lantheus Holdings' stock symbol?

Lantheus Holdings trades on the NASDAQ under the ticker symbol "LNTH."

How were Lantheus Holdings' earnings last quarter?

Lantheus Holdings, Inc. (NASDAQ:LNTH) issued its quarterly earnings results on Tuesday, August, 1st. The company reported $0.42 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.24 by $0.18. The business had revenue of $88.83 million for the quarter, compared to the consensus estimate of $80.56 million. Lantheus Holdings had a negative return on equity of 37.47% and a net margin of 8.44%. The firm's quarterly revenue was up 13.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.24 earnings per share. View Lantheus Holdings' Earnings History.

When will Lantheus Holdings make its next earnings announcement?

Lantheus Holdings is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for Lantheus Holdings.

Where is Lantheus Holdings' stock going? Where will Lantheus Holdings' stock price be in 2017?

4 equities research analysts have issued 1-year price targets for Lantheus Holdings' stock. Their predictions range from $12.00 to $22.00. On average, they expect Lantheus Holdings' share price to reach $18.75 in the next year. View Analyst Ratings for Lantheus Holdings.

Who are some of Lantheus Holdings' key competitors?

Some companies that are related to Lantheus Holdings include Medpace Holdings (MEDP), Aimmune Therapeutics (AIMT), Ascendis Pharma A/S (ASND), Natus Medical Incorporated (BABY), Repligen Corporation (RGEN), Tenet Healthcare Corporation (THC), OraSure Technologies (OSUR), Varex Imaging (VREX), Sangamo Therapeutics (SGMO), Zogenix (ZGNX), Acorda Therapeutics (ACOR), LHC Group (LHCG), Epizyme (EPZM), Lexicon Pharmaceuticals (LXRX), Spectrum Pharmaceuticals (SPPI), Dermira (DERM), IRHYTHM TECH (IRTC) and Genomic Health (GHDX).

Who are Lantheus Holdings' key executives?

Lantheus Holdings' management team includes the folowing people:

Mary Anne Heino, President, Chief Executive Officer, Director
John W. Crowley, Chief Financial Officer, Treasurer
Michael P. Duffy, Senior Vice President, Strategy and Business Development, General Counsel and Secretary
Timothy Healey, Senior Vice President, Commercial
William C. Dawes JR, Vice President - Manufacturing and Operations
Carol Walker, Vice President, Quality
Simon Robinson, Vice President - Research & Pharmaceutical Development
Cesare Orlandi M.D., Chief Medical Officer
Brian A. Markison, Non-Executive Independent Chairman
Julie H. McHugh, Director

When did Lantheus Holdings IPO?

(LNTH) raised $75 million in an initial public offering (IPO) on Thursday, June 25th 2015. The company issued 7,900,000 shares at a price of $8.50-$10.50 per share. Citigroup, Jefferies, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

How do I buy Lantheus Holdings stock?

Shares of Lantheus Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lantheus Holdings' stock price today?

One share of Lantheus Holdings stock can currently be purchased for approximately $17.85.

MarketBeat Community Rating for Lantheus Holdings (NASDAQ LNTH)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		125 (Vote Outperform)
Underperform Votes:		116 (Vote Underperform)
Total Votes:		241

MarketBeat's community ratings are surveys of what our community members think about Lantheus Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Lantheus Holdings (NASDAQ:LNTH) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	1 Hold Rating, 3 Buy Ratings
Consensus Rating:	Buy (Score: 2.75)
Consensus Price Target:	$18.75 (5.04% upside)

Consensus Price Target History for Lantheus Holdings (NASDAQ:LNTH)

Analysts' Ratings History for Lantheus Holdings (NASDAQ:LNTH)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
10/12/2017	Jefferies Group LLC	Reiterated Rating	Buy	$22.00	N/A
8/2/2017	Credit Suisse Group	Boost Price Target	Neutral	$14.00 -> $19.00	N/A
7/17/2017	Cantor Fitzgerald	Initiated Coverage	Overweight	$22.00	High
11/8/2016	Royal Bank Of Canada	Boost Price Target	Outperform	$6.00 -> $12.00	N/A
4/11/2016	Robert W. Baird	Reiterated Rating	Hold		N/A

(Data available from 10/18/2015 forward)

Earnings History for Lantheus Holdings (NASDAQ:LNTH)

Earnings by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Earnings History by Quarter for Lantheus Holdings (NASDAQ LNTH)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/30/2017		$0.21					N/A
8/1/2017	Q2 2017	$0.24	$0.42	$80.56 million	$88.83 million	View	Listen
5/2/2017	Q1 2017	$0.19	$0.28	$77.75 million	$81.36 million	View	Listen
2/21/2017	Q416	$0.13	$0.18	$70.78 million	$74.35 million	View	Listen
8/4/2016	Q216	$0.06	$0.24	$72.66 million	$78.00 million	View	Listen
5/3/2016	Q116	$0.06	$0.15	$72.43 million	$76.50 million	View	Listen
2/22/2016	Q415	$0.02	$0.13	$71.47 million	$71.00 million	View	Listen
11/4/2015	Q315	$0.04	$0.18	$73.65 million	$74.10 million	View	Listen
8/4/2015	Q215	($0.14)	$0.05	$72.41 million	$73.30 million	View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Lantheus Holdings (NASDAQ:LNTH)

2017 EPS Consensus Estimate: $0.95

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	1	$0.19	$0.19	$0.19
Q2 2017	1	$0.26	$0.26	$0.26
Q3 2017	1	$0.23	$0.23	$0.23
Q4 2017	1	$0.27	$0.27	$0.27

(Data provided by Zacks Investment Research)

Dividend History for Lantheus Holdings (NASDAQ:LNTH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for Lantheus Holdings (NASDAQ:LNTH)

Insider Ownership Percentage: 2.30%
Institutional Ownership Percentage: 84.34%

Institutional Ownership by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Insider Trades by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/13/2017	John W Crowley	CFO	Sell	6,755	$18.41	$124,359.55
9/13/2017	Derace L Schaffer	Director	Sell	15,000	$17.50	$262,500.00
9/11/2017	Michael P Duffy	Insider	Sell	20,000	$16.45	$329,000.00
9/7/2017	David F Burgstahler	Director	Sell	102,958	$16.56	$1,704,984.48
9/6/2017	David F Burgstahler	Director	Sell	78,833	$16.95	$1,336,219.35
9/5/2017	Cesare Orlandi	Insider	Sell	18,000	$16.69	$300,420.00
9/5/2017	David F Burgstahler	Director	Sell	52,010	$17.08	$888,330.80
9/1/2017	David F Burgstahler	Director	Sell	6,000	$17.10	$102,600.00
8/31/2017	David F Burgstahler	Director	Sell	230,685	$17.25	$3,979,316.25
8/28/2017	David F Burgstahler	Director	Sell	91,166	$17.01	$1,550,733.66
8/16/2017	Avista Capital Partners Gp, Ll	Major Shareholder	Sell	12,128	$17.05	$206,782.40
8/16/2017	David F Burgstahler	Director	Sell	140,846	$17.27	$2,432,410.42
8/15/2017	Avista Capital Partners Gp, Ll	Major Shareholder	Sell	40,779	$17.06	$695,689.74
8/14/2017	Avista Capital Partners Gp, Ll	Major Shareholder	Sell	87,939	$17.40	$1,530,138.60
7/12/2017	Mary Anne Heino	CEO	Sell	10,000	$18.05	$180,500.00
6/20/2017	David F Burgstahler	Director	Sell	3,000,000	$14.87	$44,610,000.00
6/12/2017	Mary Anne Heino	CEO	Sell	10,000	$15.39	$153,900.00
6/12/2017	Michael P Duffy	Insider	Sell	20,000	$15.42	$308,400.00
5/10/2017	Derace L Schaffer	Director	Sell	10,000	$15.75	$157,500.00
5/9/2017	Avista Capital Partners Gp, Ll	Major Shareholder	Sell	3,000,000	$13.40	$40,200,000.00
5/9/2017	Derace L Schaffer	Director	Sell	10,000	$14.75	$147,500.00
3/17/2017	David F Burgstahler	Director	Sell	3,000,000	$12.20	$36,600,000.00
11/21/2016	David F Burgstahler	Director	Sell	2,500,000	$9.00	$22,500,000.00

(Data available from 1/1/2013 forward)

Headline Trends for Lantheus Holdings (NASDAQ:LNTH) Latest Headlines for Lantheus Holdings (NASDAQ:LNTH)

Source:

Date	Headline
	Lantheus Holdings, Inc. (LNTH) CFO John W. Crowley Sells 6,755 Shares www.americanbankingnews.com - October 17 at 7:46 PM
	Lantheus Holdings, Inc. (LNTH) Earns "Buy" Rating from Jefferies Group LLC www.americanbankingnews.com - October 15 at 6:32 PM
	Lantheus Holdings, Inc. (LNTH) Given Consensus Rating of "Buy" by Analysts www.americanbankingnews.com - October 6 at 2:32 AM
	Should Value Investors Consider Lantheus Holdings (LNTH) Stock? - Nasdaq www.nasdaq.com - October 3 at 3:10 AM
	Should Value Investors Consider Lantheus Holdings (LNTH) Stock? finance.yahoo.com - October 2 at 12:18 PM
	TransEntrix Progresses Toward FDA Approval for Senhance - Nasdaq www.nasdaq.com - September 21 at 4:00 PM
	Surmodics Receives FDA's Approval for PTA Balloon Catheter finance.yahoo.com - September 20 at 2:43 AM
	Derace L. Schaffer Sells 15,000 Shares of Lantheus Holdings, Inc. (LNTH) Stock www.americanbankingnews.com - September 14 at 11:16 PM
	Lantheus Holdings, Inc. to Present at 2017 Cantor Fitzgerald Global Healthcare Conference finance.yahoo.com - September 14 at 7:19 AM
	Michael P. Duffy Sells 20,000 Shares of Lantheus Holdings, Inc. (LNTH) Stock www.americanbankingnews.com - September 13 at 8:28 PM
	Insider Selling: Lantheus Holdings, Inc. (LNTH) Director Sells 102,958 Shares of Stock www.americanbankingnews.com - September 11 at 10:20 PM
	Lantheus Holdings, Inc. (LNTH) Receives Consensus Recommendation of "Buy" from Analysts www.americanbankingnews.com - September 11 at 2:22 AM
	Lantheus Holdings, Inc. (LNTH) Insider Sells $300,420.00 in Stock www.americanbankingnews.com - September 7 at 7:42 PM
	Lantheus Holdings, Inc. (LNTH) Director David F. Burgstahler Sells 78,833 Shares www.americanbankingnews.com - September 6 at 10:26 PM
	David F. Burgstahler Sells 52,010 Shares of Lantheus Holdings, Inc. (LNTH) Stock www.americanbankingnews.com - September 6 at 10:26 PM
	Lantheus Holdings, Inc. (LNTH) Director David F. Burgstahler Sells 6,000 Shares www.americanbankingnews.com - September 6 at 10:26 PM
	Hologic (HOLX) Launches Brevera, Progresses in Breast Health finance.yahoo.com - September 5 at 4:11 PM
	Ride Out MedTech Volatility With These 3 Ultra-Safe Stocks finance.yahoo.com - September 5 at 4:11 PM
	Medtronic (MDT) & Mazor Robotics Tie-Up Reaches Next Level finance.yahoo.com - September 5 at 4:11 PM
	Quest Diagnostics (DGX) Banks on Buyouts, Competition Rife finance.yahoo.com - September 5 at 4:11 PM
	Henry Schein Joins IMF & LUGFA on Prostate Cancer Awareness finance.yahoo.com - September 5 at 4:11 PM
	David F. Burgstahler Sells 230,685 Shares of Lantheus Holdings, Inc. (LNTH) Stock www.americanbankingnews.com - August 31 at 10:22 PM
	Here's Why You Should Buy Lantheus Holdings (LNTH) Right Now www.zacks.com - August 31 at 6:56 AM
	Reviewing Lantheus Holdings (LNTH) and TrovaGene (TROV) www.americanbankingnews.com - August 29 at 8:40 AM
	Insider Selling: Lantheus Holdings, Inc. (LNTH) Director Sells 91,166 Shares of Stock www.americanbankingnews.com - August 28 at 10:22 PM
	ETFs with exposure to Lantheus Holdings, Inc. : August 25, 2017 finance.yahoo.com - August 26 at 6:50 AM
	Financial Survey: Lantheus Holdings (LNTH) versus NanoString Technologies (NSTG) www.americanbankingnews.com - August 23 at 9:16 AM
	Align Technology's Invisalign Sales Strong Amid Margin Woes finance.yahoo.com - August 22 at 3:35 PM
	Omnicell (OMCL) Gains on Product Launches, Competition Rife finance.yahoo.com - August 22 at 3:35 PM
	Here's Why Investors Should Buy Amedisys (AMED) Right Now finance.yahoo.com - August 22 at 3:35 PM
	Here's Why You Must Add Chemed (CHE) Stock to Your Portfolio www.zacks.com - August 21 at 7:37 PM
	NanoString Technologies (NSTG) versus Lantheus Holdings (LNTH) Financial Review www.americanbankingnews.com - August 21 at 8:09 AM
	Analyzing Lantheus Holdings (LNTH) and NanoString Technologies (NSTG) www.americanbankingnews.com - August 18 at 10:46 AM
	Walgreens' (WBA) Research Website to Add Value in Healthcare www.zacks.com - August 18 at 6:29 AM
	Lantheus Holdings, Inc. (LNTH) Given Consensus Recommendation of "Buy" by Brokerages www.americanbankingnews.com - August 17 at 8:38 AM
	Avista Capital Partners Gp, Ll Sells 12,128 Shares of Lantheus Holdings, Inc. (LNTH) Stock www.americanbankingnews.com - August 16 at 10:44 PM
	Lantheus Holdings, Inc. (LNTH) Major Shareholder Avista Capital Partners Gp, Ll Sells 87,939 Shares www.americanbankingnews.com - August 16 at 10:28 PM
	Lantheus Holdings, Inc. (LNTH) Major Shareholder Avista Capital Partners Gp, Ll Sells 40,779 Shares www.americanbankingnews.com - August 16 at 10:26 PM
	Lantheus Holdings, Inc. (LNTH) Director Sells $2,432,410.42 in Stock www.americanbankingnews.com - August 16 at 10:26 PM
	Lantheus Holdings, Inc. breached its 50 day moving average in a Bearish Manner : LNTH-US : August 15, 2017 finance.yahoo.com - August 16 at 5:37 AM
	ETFs with exposure to Lantheus Holdings, Inc. : August 15, 2017 finance.yahoo.com - August 16 at 5:37 AM
	Critical Review: NanoString Technologies (NSTG) & Lantheus Holdings (LNTH) www.americanbankingnews.com - August 10 at 2:38 PM
	Lantheus Holdings, Inc. (NASDAQ:LNTH) to Post FY2017 Earnings of $0.99 Per Share, Cantor Fitzgerald Forecasts www.americanbankingnews.com - August 9 at 8:52 AM
	Reviewing Biocept (BIOC) and Lantheus Holdings (NASDAQ:LNTH) www.americanbankingnews.com - August 8 at 2:24 PM
	Financial Comparison: Lantheus Holdings (NASDAQ:LNTH) and Biocept (BIOC) www.americanbankingnews.com - August 4 at 6:28 PM
	Q3 2017 Earnings Estimate for Lantheus Holdings, Inc. Issued By Jefferies Group (NASDAQ:LNTH) www.americanbankingnews.com - August 4 at 7:16 AM
	Lantheus Holdings, Inc. breached its 50 day moving average in a Bearish Manner : LNTH-US : August 3, 2017 finance.yahoo.com - August 4 at 12:42 AM
	Equities Analysts Offer Predictions for Lantheus Holdings, Inc.'s Q4 2017 Earnings (NASDAQ:LNTH) www.americanbankingnews.com - August 3 at 12:52 PM
	Lantheus Holdings, Inc. :LNTH-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017 finance.yahoo.com - August 3 at 3:14 AM
	Lantheus Holdings, Inc. (NASDAQ:LNTH) Issues Quarterly Earnings Results, Beats Expectations By $0.18 EPS www.americanbankingnews.com - August 2 at 3:28 PM

Lantheus Holdings (LNTH) Chart for Wednesday, October, 18, 2017

This page was last updated on 10/18/2017 by MarketBeat.com Staff

Lantheus Holdings Company Profile (NASDAQ:LNTH)

About Lantheus Holdings (NASDAQ:LNTH)

What is Lantheus Holdings' stock symbol?

How were Lantheus Holdings' earnings last quarter?

When will Lantheus Holdings make its next earnings announcement?

Where is Lantheus Holdings' stock going? Where will Lantheus Holdings' stock price be in 2017?

Who are some of Lantheus Holdings' key competitors?

Who are Lantheus Holdings' key executives?

When did Lantheus Holdings IPO?

How do I buy Lantheus Holdings stock?

What is Lantheus Holdings' stock price today?

Analyst Ratings

Earnings

Estimates

Dividends

Insider Trades

Headlines

Social

Chart